EU Cancels Order For Traditional Vaccines
It has made some wonder if the Commission, particularly Von der Leyen, is not intentionally side-lining vaccines that could compete with Pfizer products.
It has made some wonder if the Commission, particularly Von der Leyen, is not intentionally side-lining vaccines that could compete with Pfizer products.
The Valneva CEO does not intend to give up, as he explains that he regularly receives a very large number of requests from Europeans looking for a traditional vaccine solution against the COVID-19 virus.
To submit a pitch for consideration:
submissions@
For subscription inquiries:
subscriptions@